Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
Navigate Novartis
Patients & Caregivers
Healthcare Professionals
Media
Investors
Job Seekers
Global
Novartis site directory
Our Company
Our Leadership
Board of Directors
Executive Committee of Novartis
Our Approach
Strategy
Corporate Responsibility
Diversity & Inclusion
Culture and Values
Our Business
Global Product Portfolio
Innovative Medicines
Novartis Pharmaceuticals
Novartis Oncology
Sandoz
Media
Newsroom
News Archive
Multimedia Resources
Subscribe to Updates
Investors
Event Calendar
Financial Data
Share Data & Analysis
Shareholder Information
Our Focus
Disease Areas
Cancer
Cardiovascular, Renal & Metabolism
Immunology & Dermatology
Ophthalmology
Neuroscience
Respiratory
Platforms and Technology
Artificial Intelligence
Cell & Gene Therapy
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
People and Culture
Our Science
Research & Early Development
Novartis Institutes for BioMedical Research
Research Disease Areas
Postdoc Program
Open Source Science
Drug Development at Novartis
Global Clinical Pipeline
Translational Medicine
Novartis Clinical Trials
Global Product Portfolio
Science Stories
Discovery
From Our Labs
Careers
Your Career
Novartis Career Search
Careers in Digital
Careers in Research
Working at Novartis
Diversity & Inclusion
Culture and Values
Corporate Responsibility
Academic Programs
Students and Scholars
Novartis Quantitative Sciences Hackathon
Search
Gene Testing
View All Stories
From Our Labs
Neuroscientists target Alzheimer’s “silent stage”
Patient Perspectives
Lung Cancer: To test or not to test
Patient Perspectives
Your Genes, Your Melanoma
Discovery
Clinical trials make a move toward mice
Discovery
Genetic testing for Alzheimer’s disease risk
From Our Labs
Chemical genetics: The sleuthing behind modern drug discovery
Discovery
Novartis researches SMA’s genetic roots
